UK Market News
Tag Archives: Pharmaceuticals
Pfizer

Shares of Pfizer Inc. dropped by 2 percent after removing its cholesterol fighting drug from its profile as large clinical trials proved the incremental ineffectiveness of the drug, pushing the company to lower its 2016 earnings guidance. The...

By Kim Irwin on Nov 1st, 2016
Starboard Chief

The letter was issued by Managing Member of Starboard Value, Jeffrey C. Smith. Starboard Value LP released a statement on Monday disclosing a 4.6 percent holding in Perrigo Co Plc and stated that the Dublin-based drugmaker trades at a significant...

By Terry Fitzroy on Sep 12th, 2016

As Pfizer’s patents expire it is attempting to boost it’s product range. Pfizer Inc. has agreed to buy a part of the antibiotic drug business of AstraZeneca for a maximum of $1.575 billion plus royalties to help its product range...

By Kim Irwin on Aug 24th, 2016
Valeant

Valeant’s earnings came in below analyst expectations. Quebec-based Valeant Pharmaceuticals announced a significant loss during the recent quarter as management said it will go through a shake-up to fix its complicated status. The drug-maker...

By Warren Smith on Aug 9th, 2016
Bristol-Myers Squibb

Investor projections showed the company could have earned billions of dollars in sales from the cancer drug. Bristol-Myers Squibb shares plummeted over 17 percent on Friday morning after the pharmaceutical firm disclosed its cancer drug “Opdivo”...

By John Shepherd on Aug 5th, 2016

CVS’s CEO assured investors after recent losses of large public deals recently. US healthcare provider CVS Health Corporation increased its profit forecast for the whole year due to its pharmacy business which boosted revenues enabling...

By Terry Fitzroy on Aug 2nd, 2016